Atlas Trials

Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia

Clinical trial NCT04529382 · UNKNOWN

Trial details

NCT number
NCT04529382
Sponsor
Leiden University Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Fetal and Neonatal Alloimmune ThrombocytopeniaLong Term Adverse EffectsNeurodevelopmental AbnormalityIntravenous Immunoglobulin Adverse Reaction
Start date
2019-12-17
Primary completion
2020-12-17
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.